AKROSWISS
Akroswiss is a Swiss pharmaceutical company that is developing new intranasal formulations in CNS.
AKROSWISS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2007-06-07
Address:
Zug, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.akroswiss.ch
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3 M CHF
Technology used in webpage:
Organization Schema Person Schema U.S. Server Location
Similar Organizations
Alvion Pharmaceuticals P.C.
Pharmaceutical company
Amyndas Pharmaceuticals S.A.
Amyndas is a pharmaceutical company
Dayton Therapeutics
Pharmaceuticals, Biotech, Oncology
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Mits lifesciences
Pharmaceuticals company
Novo Nordisk Pharmatech
Pharmaceutical company
Palmira Biopharma
Biopharmaceutical company
Current Employees Featured
Founder
Official Site Inspections
http://www.akroswiss.ch Semrush global rank: 7.35 M Semrush visits lastest month: 805
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Akroswiss"
Pharmaceutical company | Akroswiss | Zug
May 17, 2021 Due to its heritage in MRI research, Akroswiss is focusing primarily on the claustrophobia problematic encountered at MRI examinations. In Europe about 50 million MRI scans are performed annually and about 10-20% …See details»
Akroswiss - Crunchbase Company Profile & Funding
Organization. Akroswiss . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Akroswiss - LinkedIn
Akroswiss is a swiss based pharmaceutical company, fully dedicated to the development and commercialization of innovative nasal applications of midazolam.See details»
AKROSWISS AG Company Profile | Zug, ZUG, Switzerland
Find company research, competitor information, contact details & financial data for AKROSWISS AG of Zug, ZUG. Get the latest business insights from Dun & Bradstreet.See details»
Akroswiss Company Profile 2025: Valuation, Funding & Investors
Www.akroswiss.ch. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. Baarerstrasse 2; 6300 Zug; Switzerland ... Bernhard Schuknecht, …See details»
Akroswiss takes a step forward in the interest of patients closing a ...
May 17, 2021 Akroswiss has successfully developed and tested a unique Bi-dose nasal drug delivery device for Midazolam with a first-class 360° functionality. The development of these …See details»
Akroswiss AG - startup.ch
Akroswiss AG: Akroswiss aims to develop, manufacture, and commercialize innovative nasal treatments in CNS. We are pursuing EMA marketing authorization for our two indications in …See details»
AKROSWISS, A World Intellectual Property Organization …
AKROSWISS is a WIPO trademark and brand of AKROSWISS AG, Baarerstrasse 2, CH-6300 Zug,SWITZERLAND. This trademark was filed to WIPO on Tuesday, April 4, 2023. The …See details»
Akroswiss - Overview, News & Similar companies | ZoomInfo.com
Akroswiss Closes Multi-Million CHF Seed Funding Round Akroswiss, a Zug, Switzerland-based developer of an innovative and patented Midazolam-based nasal spray to treat patients …See details»
Akroswiss AG - Drug pipelines, Patents, Clinical trials - Synapse
Explore Akroswiss AG with its drug pipeline, therapeutic area, technology platform, .See details»
Akroswiss Overview | SignalHire Company Profile
Akroswiss is a swiss based pharmaceutical company, fully dedicated to the development and commercialization of innovative nasal applications of midazolam. ... Organization Website. …See details»
AKROSWISS AG :: Switzerland :: OpenCorporates
Free and open company data on Switzerland company AKROSWISS AG (company number 855982), Baarerstrasse, 2, Zug, 6300. Learn how to leverage transparent company data at …See details»
Akroswiss - Products, Competitors, Financials, Employees, …
May 18, 2021 Akroswiss is a pharmaceutical company focused on the development of innovative nasal treatments in the central nervous system (CNS) domain. The company specializes in …See details»
Akroswiss' Leadership Team Team - Team members and org chart
The Akroswiss leadership team has a wealth of experience in various industries, including management consulting, finance, and accounting. The team members have also received …See details»
Start-up develops nasal spray against fear - ZUG4YOU
The so-called seed financing was provided by Akroswiss AG, based in Zug, which also manages the licensing rights. Akroswiss employs only a handful of people, but relies on many external …See details»
News - Akroswiss
Akroswiss takes a step forward in the interest of patients closing a multi-million CHF funding round. ZUG, Switzerland: May 17, 2021 Akroswiss is developing an innovative and patented …See details»
Akroswiss - Contacts, Employees, Board Members, Advisors
Organization. Akroswiss . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Akroswiss has 2 …See details»
Akroswiss gets funding for development of midazolam nasal spray …
May 17, 2021 Akroswiss bi-dose spray is easy to administer and more hygienic than any other solution. Relief of anxiety by endonasal administration is a safe, effective route to improve …See details»
Akroswiss Closes Multi-Million CHF Seed Funding Round - FinSMEs
May 18, 2021 Akroswiss, a Zug, Switzerland-based developer of an innovative and patented Midazolam-based nasal spray to treat patients suffering from claustrophobia and epileptic …See details»
Akros AG - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Akros AG of Root, LUZERN. Get the latest business insights from Dun & Bradstreet.See details»